Is Alphabet Stock No Longer a Good Bet?
Alphabet tripled its price per share over the past 5…
Sell
48
ASND Quote, Financials, Valuation and Earnings
Last price:
$166.13
Seasonality move
:
-9.72%
Day range:
$163.93 - $168.97
52-week range:
$111.09 - $169.37
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
24.32x
P/B ratio:
--
Volume:
393K
Avg. volume:
552K
1-year change:
11.96%
Market cap:
$9.9B
Revenue:
$393.6M
EPS (TTM):
-$7.13
ASND Analysts' Consensus Rating
The 13 analysts providing 12-month price projections for Ascendis Pharma AS shares anticipate an average target of $211.04, ranging from a low estimate of $161.42 to a high estimate of $291.83. This average target implies a growth of 28.18% compared to the current stock price of $164.65.
Consensus Price Target
$211.04
Highest Price Target
$291.83
Lowest Price Target
$161.42
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 10 | 12 | 12 |
| Hold | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
ASND Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Pepsi Vs Coke Stock: Which Is Best?
Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…
Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
52
RGC alert for Mar 19
Regencell Bioscience Holdings [RGC] is down 0.66% over the past day.
Sell
49
SRPT alert for Mar 19
Sarepta Therapeutics [SRPT] is up 8.72% over the past day.
Sell
46
CVNA alert for Mar 19
Carvana [CVNA] is up 5.74% over the past day.
